SINOVAC BIOTECH LTD financials

  1. Home
  2. Financials
  3. SVA
SVA CIK 0001084201

Source: EDGAR filings · Built 2026-06-19T03:11:37Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -561.10M -152.85M -17.52M -1.11B 14.73B 351.82M
EBITDA -391.35M -394.26M -555.54M -355.84M 17.70B 219.44M
Working Capital 5.52B 9.19B 10.30B 10.05B 12.42B 880.68M
Net Debt 17.37M 56.05M -643.04M -3.28B -10.84B -916.91M
Gross Margin 67.87% 61.07% 68.77% 55.33% 94.89% 86.84%
Operating Margin -126.97% -139.89% -151.86% -34.54% 90.98% 42.23%
Net Margin -51.51% 11.25% -2.87% 0.98% 41.94% 21.61%
Return on Equity (ROE) -4.48% 0.49% -0.16% 0.17% 90.30% 14.79%
Return on Assets (ROA) -2.33% 0.33% -0.10% 0.10% 48.47% 5.80%
Current Ratio 4.59× 7.33× 8.97× 9.00× 5.93× 2.30×
Debt-to-Equity 0.11× 0.05× 0.06× 0.07× 0.09× 0.17×
Effective Tax Rate 24.14% 5.09% -43.05% -23.68% 19.63% 14.51%
Cash Conversion Ratio 2.58× -1.40× -10.28× -55.17× 1.89× 4.34×
Accruals Ratio 0.04× 0.01× -0.01× 0.06× -0.43× -0.19×
SBC % of Revenue 0.00% 0.00% 0.00% 0.00% 0.04% 2.00%
CapEx Coverage -10.47× -0.59× 0.89× -2.54× 25.79× 3.76×
Free Cash Flow Per Share $-7.81 $-2.13 $-0.24 $-15.49 $205.70 $3.10

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 386.01M 361.37M 470.17M 1.47B 19.37B 510.62M
Cost of Revenue 124.03M 140.69M 146.85M 658.19M 988.92M 67.18M
Gross Profit 261.98M 220.69M 323.32M 815.24M 18.38B 443.44M
Research and Development Expense 216.18M 270.66M 350.19M 478.69M 152.70M 48.76M
Selling, General and Administrative Expense 332.98M 420.92M 598.25M 836.14M 602.15M 176.53M
Operating Expenses 752.11M 726.22M 1.04B 1.32B 758.06M 227.80M
Operating Income (Loss) -490.13M -505.54M -713.98M -508.99M 17.62B 215.64M
Income Tax Expense (Benefit) -63.27M 2.18M 36.37M 11.48M 3.45B 31.44M
Net Income (Loss) Attributable to Parent — — -13.49M 14.47M 8.12B 110.37M
Earnings Per Share, Basic $-0.83 $1.27 $-0.19 $0.20 $113.54 $1.06
Weighted Average Number of Shares Outstanding, Basic 71.86M 71.86M 71.83M 71.72M 71.53M 98.90M
Earnings Per Share, Diluted $-0.83 $1.27 $-0.19 $0.20 $113.44 $0.97
Weighted Average Number of Shares Outstanding, Diluted 71.86M 71.86M 71.85M 71.76M 71.60M 113.66M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 488.25M 335.27M 1.12B 3.88B 11.61B 1.04B
Assets, Current 7.06B 10.64B 11.60B 11.30B 14.94B 1.56B
Assets 8.54B 12.34B 13.61B 14.03B 16.76B 1.90B
Long-term Debt 494.86M 375.76M 253.91M 11.81M 15.77M 35.10M
Liabilities, Current 1.54B 1.45B 1.29B 1.26B 2.52B 679.61M
Liabilities 2.15B 2.04B 1.97B 1.79B 3.21B 781.20M
Stockholders' Equity Attributable to Parent 4.44B 8.26B 8.32B 8.49B 9.00B 746.47M
Common Stock, Shares, Outstanding 71.86M 71.86M 71.86M 71.72M 71.72M 99.29M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -512.18M -56.89M 138.65M -798.12M 15.32B 479.31M
Payments to Acquire Property, Plant, and Equipment 48.92M 95.96M 156.16M 313.86M 594.21M 127.49M
Net Cash Provided by (Used in) Investing Activities 4.39B 456.36M -2.70B -6.09B -2.98B -204.76M
Payments of Dividends 3.53B 947.00M 328.08M 247.40M 1.88B 0
Net Cash Provided by (Used in) Financing Activities -3.43B -823.95M -88.55M -299.53M -1.91B 592.57M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (SVA CIK 0001084201), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CYPH

CYPHERPUNK TECHNOLOGIES INC.

MNSB

MainStreet Bancshares, Inc.

UHT

UNIVERSAL HEALTH REALTY INCOME TRUST